Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106187657A reveals stable PdMgAl-LDH catalyst for Suzuki reactions. Reduces palladium pollution and enables scalable pharmaceutical intermediates manufacturing with cost efficiency.
Patent CN105646231B introduces a green alcoholysis method for 2,4-dichloro-5-nitrophenol, offering higher purity and reduced waste for oxadiazon manufacturing supply chains.
Patent CN107827764A reveals ionic liquid catalysis for bis-beta-amino ketones. Achieve high purity and cost reduction in fine chemical manufacturing with scalable routes.
Patent CN104326987B reveals water-phase catalytic synthesis for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Discover a novel metal-free amidation method via patent CN111039813B. Achieve cost reduction in pharmaceutical manufacturing with mild conditions and high yields.
Novel chromium-free oxidation route for high-purity diacerein production ensuring cost efficiency and supply chain stability.
Patent CN112979602B reveals a safer, scalable route for Baloxavir Marboxil intermediates, eliminating toxic selenium and cryogenic conditions for reliable supply.
Novel photo-copper catalysis method enables efficient delta-lactone synthesis with high enantioselectivity. This technology offers reliable supply chain solutions and cost reduction in pharmaceutical intermediate manufacturing for global partners.
Patent CN111116552B details a novel one-step synthesis of quinazolinones using vinyl heterocycles, offering high purity and scalable routes for pharmaceutical intermediate suppliers.
Novel metal-free electrocatalytic route for benzothiophene derivatives. High purity, room temperature, scalable process for API intermediates.
Novel enzymatic route for Sacubitril intermediate. High purity, cost-effective, scalable manufacturing for cardiovascular API supply chains.
Novel Cu(phen)2BF4 catalyst enables efficient diphenyl ether synthesis. Reduces costs and improves supply chain reliability for pharma and fragrance intermediates.
Patent CN116024187B enables enzymatic synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113072517B reveals a metal-free organocatalytic route for five-membered heterocycles, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN113501766B details a novel asymmetric synthesis route for difluoroalkyl cyclopentenones using visible light catalysis, offering high purity and cost reduction in pharmaceutical manufacturing.
Patent CN115850336B reveals metal-free synthesis for high-purity axial chiral compounds. Enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Enzymatic synthesis patent CN104630297B offers high-purity Rosuvastatin intermediate with reduced cost and scalable supply chain reliability for global buyers.
Novel patent method reduces cost and waste for 5-iodo-2-bromobenzyl alcohol production ensuring high purity and supply chain reliability for global buyers.
Patent CN105732377B reveals high-yield indanone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthesis of Tetrabenazine API intermediate using imine salts. Reduces cost and improves regioselectivity compared to conventional methods.